New drug would change clinical practice against m’s cancer

In Coahuila breast cancer patients Her dos positive, currently treated with chemotherapies could do without a invasive treatment and be treated as effectively as through intravenous treatment with the application of Trastuzumab Ematansine (T-DM1), the oncologist Omar Peña Curiel, specialist in breast cancer, attached to the Breast Cancer Center of the Zambrano Hellion-TecSalud Hospital.

The doctor indicated that as of September with the approval of the authorities of Health the drug is available for the public sector, which would save and increase the quality of life de many patients in condition since Coahuila it ranks fourth nationally for deaths from Breast Cancer.

“A drug is available called Trastuzumab Emtansine, this is a relatively new drug that is available in Mexico, and that we can use with patients with Cabreast cancer, in a particular subtype called Her2 positive which represents 15 to 20% of patients with breast cancer ”, detailed.

He added that, “eThis drug is administered intravenously that helps us to prolong the survival of patients. Talking about an effectiveness rate is complex, because it can be used in different scenarios; When the majority of patients are diagnosed, the intention of the treatment is to cure them of the disease, but in a positive Her2 patient we can use it in a setting where it is already healing in order to reduce the possibility of the Cancer returning “he pointed.

He highlighted that in patients in whom the cancer is advanced, and it left the breast it invaded the lung, liver or bone the objective is to improve the quality of life and prolonging the life span of the patient, as a second line of treatment.

“It is recently available in the public sector in some states of the Republic, including in Coahuila, which is excellent news, but we have to make it known to the public that it is a treatment that can only be indicated and supervised by the treating physician”, concluded.

– .